脱毛症の市場規模、シェア、動向分析レポート：疾患タイプ別、治療法別、性別、販売チャネル別、最終用途別、地域別、セグメント別予測、2024年～2030年

脱毛症市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、脱毛症の世界市場規模は2024年から2030年にかけてCAGR 9.1%を記録し、2030年には160億2,000万米ドルに達すると予測されています。

JAK阻害剤とチロシンキナーゼ阻害剤の承認と対象疾患の有病率の上昇が市場成長の原動力になると予想されます。

円形脱毛症（AA）および全頭脱毛症の有病率は世界的に増加しています。2023年3月に発表された調査論文によると、米国と英国では、皮膚科クリニックで新たに遭遇する症例の0.6％～2％が円形脱毛症です。世界中で行われた病院ベースの調査では、AAの発生率は0.57％から3.8％と推定されています。

新しい標的治療薬の承認は、脱毛症市場の成長を促進する重要な要因です。例えば、2022年6月、米国FDAはリリーのOlumiant経口錠剤を成人患者の重症脱毛症の治療薬として承認し、承認された最初の全身治療薬となった。2023年に承認されると予想されるもう一つの重要な薬剤は、ファイザーのリトレシチニブです。これはヤヌスキナーゼ3（JAK3）とチロシンキナーゼの二重阻害剤です。

業界の成長を促進するもう一つの重要な要因は、脱毛症に対する意識の高まりと、それによる世界の治療率の上昇です。外見に関する意識レベルの向上は、治療を求める人々が増加している主な理由の一つです。さらに、研究開発や資金調達への投資が増加していることも、市場の成長を後押ししています。

基礎疾患を治療する標的治療薬の入手可能性が限られていることは、同市場にとって重要な課題の1つです。標的作用機序を持つ新製品が承認されつつある一方で、既に承認された製品に比べこれらの薬剤のコストが高いことが、普及を妨げる大きな要因の一つとなっています。

脱毛症市場レポートハイライト

• 登録前段階にあるPfizer社のRitlecitinibや、第2相臨床試験段階にあるBioniz Therapeutics社のBNZ-1などのパイプライン製品の承認が目前に迫っていることから、2024年から2030年にかけては、円形脱毛症分野が最も急成長すると予想されます。
• 2023年の市場は北米が支配的であったが、これは主に消費者意識の高さ、技術の進歩、対象疾患人口の多さ、ヘルスケア支出の多さによるものです。
• アジア太平洋地域は予測期間中に最も高いCAGRで成長すると予想されます。これは主に、対象疾患人口の増加と疾患治療率の上昇に起因しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 脱毛症の市場変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 脱毛症市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
• 価格分析

第4章 脱毛症市場：疾患 推定・動向分析

• 疾患タイプの市場シェア、2023年および2030年
• セグメントダッシュボード
• 疾患別の世界の脱毛症市場の見通し

第5章 脱毛症市場：治療 推定・動向分析

• 治療市場シェア、2023年と2030年
• セグメントダッシュボード
• 治療別の世界の脱毛症市場の見通し

第6章 脱毛症市場：性別 推定・動向分析

• 男女別市場シェア、2023年と2030年
• セグメントダッシュボード
• 男女別の世界の脱毛症市場の見通し

第7章 脱毛症市場：販売チャネル 推定・動向分析

• 販売チャネル市場シェア、2023年と2030年
• セグメントダッシュボード
• 販売チャネル別の世界の脱毛症市場の見通し

第8章 脱毛症市場：最終用途 推定・動向分析

• 最終用途市場シェア、2023年および2030年
• セグメントダッシュボード
• 最終用途別の世界の脱毛症市場の見通し

第9章 脱毛症市場：地域 推定・動向分析

• 地域市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 市場規模と予測トレンド分析、2018年から2030年：
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
• ベンダー情勢
  • List of key distributors and channel partners
  • Key customers
  • Key company market share analysis, 2023
  • Janssen Global Services Inc.
  • Cipla Limited
  • Merck &Co., Inc.
  • GlaxoSmithKline plc
  • Sun Pharmaceuticals Industries Ltd
  • Dr. Reddy's Laboratories Ltd
  • Aurobindo Pharma
  • Viatris Inc.
  • Pfizer, Inc.
  • Lilly
  • Lexington Intl., LLC（Devices）
  • Freedom Laser Therapy（iRestore ID-520 helmet）
  • Curallux, LLC.
  • Apira Science Inc.（iGROW Laser）
  • Revian Inc.
  • Theradome
  • Lutronic

List of Tables

• Table 1 List of abbreviation
• Table 2 North America alopecia market, by region, 2018 - 2030 (USD Million)
• Table 3 North America alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 4 North America alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 5 North America alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 6 North America alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 7 North America alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 8 U.S. alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 9 U.S. alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 10 U.S. alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 11 U.S. alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 12 U.S. alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 13 Canada alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 14 Canada alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 15 Canada alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 16 Canada alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 17 Canada alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 18 Europe alopecia market, by region, 2018 - 2030 (USD Million)
• Table 19 Europe alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 20 Europe alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 21 Europe alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 22 Europe alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 23 Europe alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 24 Germany alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 25 Germany alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 26 Germany alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 27 Germany alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 28 Germany alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 29 UK alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 30 UK alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 31 UK alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 32 UK alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 33 UK alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 34 France alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 35 France alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 36 France alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 37 France alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 38 France alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 39 Italy alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 40 Italy alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 41 Italy alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 42 Italy alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 43 Italy alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 44 Spain alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 45 Spain alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 46 Spain alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 47 Spain alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 48 Spain alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 49 Denmark alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 50 Denmark alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 51 Denmark alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 52 Denmark alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 53 Denmark alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 54 Sweden alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 55 Sweden alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 56 Sweden alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 57 Sweden alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 58 Sweden alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 59 Norway alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 60 Norway alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 61 Norway alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 62 Norway alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 63 Norway alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific alopecia market, by region, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 66 Asia Pacific alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 67 Asia Pacific alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 68 Asia Pacific alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 69 Asia Pacific alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 70 China alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 71 China alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 72 China alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 73 China alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 74 China alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 75 Japan alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 76 Japan alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 77 Japan alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 78 Japan alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 79 Japan alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 80 India alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 81 India alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 82 India alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 83 India alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 84 India alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 85 South Korea alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 86 South Korea alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 87 South Korea alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 88 South Korea alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 89 South Korea alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 90 Australia alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 91 Australia alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 92 Australia alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 93 Australia alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 94 Australia alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 95 Thailand alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 96 Thailand alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 97 Thailand alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 98 Thailand alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 99 Thailand alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 100 Latin America alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 101 Latin America alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 102 Latin America alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 103 Latin America alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 104 Latin America alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 105 Brazil alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 106 Brazil alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 107 Brazil alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 108 Brazil alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 109 Brazil alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 110 Mexico alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 111 Mexico alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 112 Mexico alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 113 Mexico alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 114 Mexico alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 115 Argentina alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 116 Argentina alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 117 Argentina alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 118 Argentina alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 119 Argentina alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 120 MEA alopecia market, by region, 2018 - 2030 (USD Million)
• Table 121 MEA alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 122 MEA alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 123 MEA alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 124 MEA alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 125 MEA alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 126 South Africa alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 127 South Africa alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 128 South Africa alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 129 South Africa alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 130 South Africa alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 131 Saudi Arabia alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 132 Saudi Arabia alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 133 Saudi Arabia alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 134 Saudi Arabia alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 135 Saudi Arabia alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 136 UAE alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 137 UAE alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 138 UAE alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 139 UAE alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 140 UAE alopecia market, by end user, 2018 - 2030 (USD Million)
• Table 141 Kuwait alopecia market, by disease type, 2018 - 2030 (USD Million)
• Table 142 Kuwait alopecia market, by treatment, 2018 - 2030 (USD Million)
• Table 143 Kuwait alopecia market, by gender, 2018 - 2030 (USD Million)
• Table 144 Kuwait alopecia market, by sales channel, 2018 - 2030 (USD Million)
• Table 145 Kuwait alopecia market, by end user, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Alopecia market: market outlook
• Fig. 14 Alopecia competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 Alopecia market driver impact
• Fig. 20 Alopecia market restraint impact
• Fig. 21 Alopecia market strategic initiatives analysis
• Fig. 22 Alopecia market: Disease type movement analysis
• Fig. 23 Alopecia market: Disease type outlook and key takeaways
• Fig. 24 Alopecia areata market estimates and forecast, 2018 - 2030
• Fig. 25 Male alopecia areata market estimates and forecast, 2018 - 2030
• Fig. 26 Female alopecia areata market estimates and forecast, 2018 - 2030
• Fig. 27 Cicatricial alopecia market estimates and forecast, 2018 - 2030
• Fig. 28 Male cicatricial alopecia market estimates and forecast, 2018 - 2030
• Fig. 29 Female cicatricial alopecia market estimates and forecast, 2018 - 2030
• Fig. 30 Traction alopecia market estimates and forecast, 2018 - 2030
• Fig. 31 Male traction market estimates and forecast, 2018 - 2030
• Fig. 32 Female traction market estimates and forecast, 2018 - 2030
• Fig. 33 Alopecia totalis market estimates and forecast, 2018 - 2030
• Fig. 34 Male alopecia totalis market estimates and forecast, 2018 - 2030
• Fig. 35 Female alopecia totalis market estimates and forecast, 2018 - 2030
• Fig. 36 Alopecia universalis market estimates and forecast, 2018 - 2030
• Fig. 37 Male alopecia universalis market estimates and forecast, 2018 - 2030
• Fig. 38 Female alopecia universalis market estimates and forecast, 2018 - 2030
• Fig. 39 Androgenetic alopecia market estimates and forecast, 2018 - 2030
• Fig. 40 Male androgenetic alopecia market estimates and forecast, 2018 - 2030
• Fig. 41 Female androgenetic alopecia market estimates and forecast, 2018 - 2030
• Fig. 42 Other alopecia market estimates and forecast, 2018 - 2030
• Fig. 43 Male other alopecia market estimates and forecast, 2018 - 2030
• Fig. 44 Female other alopecia market estimates and forecast, 2018 - 2030
• Fig. 45 Alopecia Market: Treatment movement Analysis
• Fig. 46 Alopecia market: Treatment outlook and key takeaways
• Fig. 47 Pharmaceuticals market estimates and forecasts, 2018 - 2030
• Fig. 48 Topical market estimates and forecasts,2018 - 2030
• Fig. 49 Topical OTC pharmaceuticals market estimates and forecasts,2018 - 2030
• Fig. 50 Topical OTC minoxidil market estimates and forecasts,2018 - 2030
• Fig. 51 Topical OTC others market estimates and forecasts,2018 - 2030
• Fig. 52 Topical prescription pharmaceuticals market estimates and forecasts,2018 - 2030
• Fig. 53 Topical prescription betamethasone dipropionate market estimates and forecasts,2018 - 2030
• Fig. 54 Topical prescription fluocinolone acetonide market estimates and forecasts,2018 - 2030
• Fig. 55 Topical prescription finasteride market estimates and forecasts,2018 - 2030
• Fig. 56 Topical prescription minoxidil market estimates and forecasts,2018 - 2030
• Fig. 57 Oral pharmaceuticals market estimates and forecasts,2018 - 2030
• Fig. 58 Oral OTC pharmaceuticals market estimates and forecasts,2018 - 2030
• Fig. 59 Oral prescription pharmaceuticals market estimates and forecasts,2018 - 2030
• Fig. 60 Oral prescription minoxidil market estimates and forecasts,2018 - 2030
• Fig. 61 Oral prescription finasteride market estimates and forecasts,2018 - 2030
• Fig. 62 Oral prescription corticosteroids market estimates and forecasts,2018 - 2030
• Fig. 63 Oral prescription others (JAK inhibitors and others) market estimates and forecasts,2018 - 2030
• Fig. 64 PRP market estimates and forecasts,2018 - 2030
• Fig. 65 Devices market estimates and forecasts,2018 - 2030
• Fig. 66 Laser cap market estimates and forecasts,2018 - 2030
• Fig. 67 Laser comb market estimates and forecasts,2018 - 2030
• Fig. 68 Laser helmet market estimates and forecasts,2018 - 2030
• Fig. 69 Alopecia market: Gender movement analysis
• Fig. 70 Alopecia market: Gender outlook and key takeaways
• Fig. 71 Male market estimates and forecasts, 2018 - 2030
• Fig. 72 Female market estimates and forecasts,2018 - 2030
• Fig. 73 Alopecia market: Sales channel movement analysis
• Fig. 74 Alopecia market: Sales channel outlook and key takeaways
• Fig. 75 Prescriptions market estimates and forecasts, 2018 - 2030
• Fig. 76 OTC market estimates and forecasts,2018 - 2030
• Fig. 77 Alopecia market: End use movement analysis
• Fig. 78 Alopecia market: End use outlook and key takeaways
• Fig. 79 Homecare settings market estimates and forecasts, 2018 - 2030
• Fig. 80 Dermatology clinics market estimates and forecasts,2018 - 2030
• Fig. 81 Global alopecia market: Regional movement analysis
• Fig. 82 Global alopecia market: Regional outlook and key takeaways
• Fig. 83 Global alopecia market share and leading players
• Fig. 84 North America market share and leading players
• Fig. 85 Europe market share and leading players
• Fig. 86 Asia Pacific market share and leading players
• Fig. 87 Latin America market share and leading players
• Fig. 88 Middle East & Africa market share and leading players
• Fig. 89 North America: SWOT
• Fig. 90 Europe SWOT
• Fig. 91 Asia Pacific SWOT
• Fig. 92 Latin America SWOT
• Fig. 93 MEA SWOT
• Fig. 94 North America, by country
• Fig. 95 North America
• Fig. 96 North America market estimates and forecasts, 2018 - 2030
• Fig. 97 U.S.
• Fig. 98 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 99 Canada
• Fig. 100 Canada market estimates and forecasts, 2018 - 2030
• Fig. 101 Europe
• Fig. 102 Europe market estimates and forecasts, 2018 - 2030
• Fig. 103 UK
• Fig. 104 UK market estimates and forecasts, 2018 - 2030
• Fig. 105 Germany
• Fig. 106 Germany market estimates and forecasts, 2018 - 2030
• Fig. 107 France
• Fig. 108 France market estimates and forecasts, 2018 - 2030
• Fig. 109 Italy
• Fig. 110 Italy market estimates and forecasts, 2018 - 2030
• Fig. 111 Spain
• Fig. 112 Spain market estimates and forecasts, 2018 - 2030
• Fig. 113 Denmark
• Fig. 114 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 115 Sweden
• Fig. 116 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 117 Norway
• Fig. 118 Norway market estimates and forecasts, 2018 - 2030
• Fig. 119 Asia Pacific
• Fig. 120 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 121 China
• Fig. 122 China market estimates and forecasts, 2018 - 2030
• Fig. 123 Japan
• Fig. 124 Japan market estimates and forecasts, 2018 - 2030
• Fig. 125 India
• Fig. 126 India market estimates and forecasts, 2018 - 2030
• Fig. 127 Thailand
• Fig. 128 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 129 South Korea
• Fig. 130 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 131 Australia
• Fig. 132 Australia market estimates and forecasts, 2018 - 2030
• Fig. 133 Latin America
• Fig. 134 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 135 Brazil
• Fig. 136 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 137 Mexico
• Fig. 138 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 139 Argentina
• Fig. 140 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 141 Middle East and Africa
• Fig. 142 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 143 South Africa
• Fig. 144 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 145 Saudi Arabia
• Fig. 146 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 147 UAE
• Fig. 148 UAE market estimates and forecasts, 2018 - 2030
• Fig. 149 Kuwait
• Fig. 150 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 151 Market share of key market players- Alopecia market

Alopecia Market Growth & Trends:

The global alopecia market size is expected to reach USD 16.02 billion by 2030, registering a CAGR of 9.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The approval of JAK inhibitors and tyrosine kinase inhibitors along with the rising target disease prevalence is expected to drive market growth.

The prevalence of alopecia areata (AA) and alopecia totalis is increasing globally. It is one of the most commonly encountered problems in clinics in the U.S. As per a research article published in March 2023, in the U.S. and UK, AA accounted for 0.6% to 2% of the new cases encountered in dermatology clinics. In hospital-based studies performed worldwide the incidence of AA is estimated to range between 0.57% to 3.8%.

The approval of new targeted pharmaceutical treatments is a key factor driving the alopecia market growth. For instance, in June 2022, the U.S. FDA approved Lilly's Olumiant oral tablets for the treatment of severe alopecia in adult patients and is the first systemic treatment approved. Another key drug that is anticipated to be approved in 2023 is Pfizer's Ritlecitinib. It is a dual inhibitor of Janus kinase 3 (JAK3) and tyrosine kinases.

Another key factor driving the industry's growth is the increasing awareness regarding alopecia and thereby increasing treatment rates worldwide. The increase in the level of consciousness regarding physical appearance is one of the major reasons for the rising number of people seeking treatment. Additionally, rising investments in R&D and funding are also fueling market growth.

The limited availability of targeted drugs that treat the underlying condition is one key challenge for the market. While new products with targeted mechanisms of action are being approved the high cost of these drugs in comparison to the already approved products is one of the major hindrances in their widespread adoption.

Alopecia Market Report Highlights:

• The alopecia universalis segment is expected to witness the fastest growth from 2024 to 2030, owing to the impending approval of pipeline products, such as Pfizer's Ritlecitinib which is in the pre-registration phase, and Bioniz Therapeutics's BNZ-1 which is in phase 2 clinical trials
• North America dominated the market in 2023, mainly due to the high consumer awareness, technological advancements, high target disease population, and high healthcare spending
• Asia Pacific is expected to grow at the highest CAGR during the forecast period. This can be majorly attributed to the rising target disease population and rising treatment rate for the disease.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Disease Type
  • 1.2.2. Treatment
  • 1.2.3. Gender
  • 1.2.4. Sales Channel
  • 1.2.5. End Use
  • 1.2.6. Regional scope
  • 1.2.7. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Disease Type
  • 2.2.2. Treatment
  • 2.2.3. Gender
  • 2.2.4. Sales Channel
  • 2.2.5. End Use
  • 2.2.6. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Alopecia Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing global prevalence of alopecia
    • 3.2.1.2. Increasing global healthcare expenditure
    • 3.2.1.3. Increasing prevalence of chronic diseases
    • 3.2.1.3.1. PCOS
    • 3.2.1.3.2. Cancer
    • 3.2.1.3.3. Rheumatoid Arthritis
    • 3.2.1.4. Technological advancements in alopecia treatment
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Lack of reimbursement policies for alopecia treatment
    • 3.2.2.2. Increasing adoption of substitutes
• 3.3. Alopecia Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
• 3.4. Pricing Analysis

Chapter 4. Alopecia Market: Disease Type Estimates & Trend Analysis

• 4.1. Disease Type Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Alopecia Market by Disease Type Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Alopecia Areata
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.2. Male
    • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.3. Female
    • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Cicatricial Alopecia
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.2. Male
    • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.3. Female
    • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Traction Alopecia
    • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3.2. Male
    • 4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3.3. Female
    • 4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Alopecia Totalis
    • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4.2. Male
    • 4.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4.3. Female
    • 4.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Alopecia Universalis
    • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5.2. Male
    • 4.4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5.3. Female
    • 4.4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.6. Androgenetic Alopecia
    • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6.2. Male
    • 4.4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6.3. Female
    • 4.4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.7. Others
    • 4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.7.2. Male
    • 4.4.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.7.3. Female
    • 4.4.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Alopecia Market: Treatment Estimates & Trend Analysis

• 5.1. Treatment Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Alopecia Market by Treatment Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Pharmaceuticals
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.2. Topical
    • 5.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.2.2. OTC
    • 5.4.1.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.2.2.2. Minoxidil
    • 5.4.1.2.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.2.2.3. Others
    • 5.4.1.2.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.2.3. Prescription
    • 5.4.1.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.2.3.2. Betamethasone Dipropionate
    • 5.4.1.2.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.2.3.3. Fluocinolone Acetonide
    • 5.4.1.2.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.2.3.4. Finasteride
    • 5.4.1.2.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.2.3.5. Minoxidil
    • 5.4.1.2.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.3. Oral
    • 5.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.3.2. OTC
    • 5.4.1.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.3.3. Prescription
    • 5.4.1.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.3.3.2. Minoxidil
    • 5.4.1.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.3.3.3. Finasteride
    • 5.4.1.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.3.3.4. Corticosteroids
    • 5.4.1.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.3.3.5. Others (JAK inhibitors and others)
    • 5.4.1.3.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.1.4. PRP
    • 5.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Devices
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2.2. Laser Cap
    • 5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2.2.2. Laser Comb
    • 5.4.2.2.3. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2.2.4. Laser Helmet
    • 5.4.2.2.5. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Alopecia Market: Gender Estimates & Trend Analysis

• 6.1. Gender Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Alopecia Market by Gender Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. Prescriptions
    • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 6.4.2. Female
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Alopecia Market: Sales Channel Estimates & Trend Analysis

• 7.1. Sales Channel Market Share, 2023 & 2030
• 7.2. Segment Dashboard
• 7.3. Global Alopecia Market by Gender Outlook
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.4.1. Prescription
    • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 7.4.2. OTC
    • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Alopecia Market: End Use Estimates & Trend Analysis

• 8.1. End Use Market Share, 2023 & 2030
• 8.2. Segment Dashboard
• 8.3. Global Alopecia Market by End Use Outlook
• 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.4.1. Homecare Settings
    • 8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 8.4.2. Dermatology Clinics
    • 8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Alopecia Market: Regional Estimates & Trend Analysis

• 9.1. Regional Market Share Analysis, 2023 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Global Regional Market Snapshot
• 9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 9.5. North America
  • 9.5.1. U.S.
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Regulatory framework/ reimbursement structure
    • 9.5.1.3. Competitive scenario
    • 9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.2. Canada
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework/ reimbursement structure
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 9.6. Europe
  • 9.6.1. UK
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Regulatory framework/ reimbursement structure
    • 9.6.1.3. Competitive scenario
    • 9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.2. Germany
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework/ reimbursement structure
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.3. France
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Regulatory framework/ reimbursement structure
    • 9.6.3.3. Competitive scenario
    • 9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.4. Italy
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Regulatory framework/ reimbursement structure
    • 9.6.4.3. Competitive scenario
    • 9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.5. Spain
    • 9.6.5.1. Key country dynamics
    • 9.6.5.2. Regulatory framework/ reimbursement structure
    • 9.6.5.3. Competitive scenario
    • 9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.6. Norway
    • 9.6.6.1. Key country dynamics
    • 9.6.6.2. Regulatory framework/ reimbursement structure
    • 9.6.6.3. Competitive scenario
    • 9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.7. Sweden
    • 9.6.7.1. Key country dynamics
    • 9.6.7.2. Regulatory framework/ reimbursement structure
    • 9.6.7.3. Competitive scenario
    • 9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.8. Denmark
    • 9.6.8.1. Key country dynamics
    • 9.6.8.2. Regulatory framework/ reimbursement structure
    • 9.6.8.3. Competitive scenario
    • 9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 9.7. Asia Pacific
  • 9.7.1. Japan
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Regulatory framework/ reimbursement structure
    • 9.7.1.3. Competitive scenario
    • 9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.2. China
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework/ reimbursement structure
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.3. India
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework/ reimbursement structure
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.4. Australia
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Regulatory framework/ reimbursement structure
    • 9.7.4.3. Competitive scenario
    • 9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.5. South Korea
    • 9.7.5.1. Key country dynamics
    • 9.7.5.2. Regulatory framework/ reimbursement structure
    • 9.7.5.3. Competitive scenario
    • 9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.6. Thailand
    • 9.7.6.1. Key country dynamics
    • 9.7.6.2. Regulatory framework/ reimbursement structure
    • 9.7.6.3. Competitive scenario
    • 9.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 9.8. Latin America
  • 9.8.1. Brazil
    • 9.8.1.1. Key country dynamics
    • 9.8.1.2. Regulatory framework/ reimbursement structure
    • 9.8.1.3. Competitive scenario
    • 9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.2. Mexico
    • 9.8.2.1. Key country dynamics
    • 9.8.2.2. Regulatory framework/ reimbursement structure
    • 9.8.2.3. Competitive scenario
    • 9.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.3. Argentina
    • 9.8.3.1. Key country dynamics
    • 9.8.3.2. Regulatory framework/ reimbursement structure
    • 9.8.3.3. Competitive scenario
    • 9.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 9.9. MEA
  • 9.9.1. South Africa
    • 9.9.1.1. Key country dynamics
    • 9.9.1.2. Regulatory framework/ reimbursement structure
    • 9.9.1.3. Competitive scenario
    • 9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.2. Saudi Arabia
    • 9.9.2.1. Key country dynamics
    • 9.9.2.2. Regulatory framework/ reimbursement structure
    • 9.9.2.3. Competitive scenario
    • 9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.3. UAE
    • 9.9.3.1. Key country dynamics
    • 9.9.3.2. Regulatory framework/ reimbursement structure
    • 9.9.3.3. Competitive scenario
    • 9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.4. Kuwait
    • 9.9.4.1. Key country dynamics
    • 9.9.4.2. Regulatory framework/ reimbursement structure
    • 9.9.4.3. Competitive scenario
    • 9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company/Competition Categorization
• 10.3. Vendor Landscape
  • 10.3.1. List of key distributors and channel partners
  • 10.3.2. Key customers
  • 10.3.3. Key company market share analysis, 2023
  • 10.3.4. Janssen Global Services Inc.
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Product benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. Cipla Limited
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Product benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. Merck & Co., Inc.
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Product benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. GlaxoSmithKline plc
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Product benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. Sun Pharmaceuticals Industries Ltd
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Product benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. Dr. Reddy's Laboratories Ltd
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Product benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. Aurobindo Pharma
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Product benchmarking
    • 10.3.10.4. Strategic initiatives
  • 10.3.11. Viatris Inc.
    • 10.3.11.1. Company overview
    • 10.3.11.2. Financial performance
    • 10.3.11.3. Product benchmarking
    • 10.3.11.4. Strategic initiatives
  • 10.3.12. Pfizer, Inc.
    • 10.3.12.1. Company overview
    • 10.3.12.2. Financial performance
    • 10.3.12.3. Product benchmarking
    • 10.3.12.4. Strategic initiatives
  • 10.3.13. Lilly
    • 10.3.13.1. Company overview
    • 10.3.13.2. Financial performance
    • 10.3.13.3. Product benchmarking
    • 10.3.13.4. Strategic initiatives
  • 10.3.14. Lexington Intl., LLC (Devices)
    • 10.3.14.1. Company overview
    • 10.3.14.2. Financial performance
    • 10.3.14.3. Product benchmarking
    • 10.3.14.4. Strategic initiatives
  • 10.3.15. Freedom Laser Therapy (iRestore ID-520 helmet)
    • 10.3.15.1. Company overview
    • 10.3.15.2. Financial performance
    • 10.3.15.3. Product benchmarking
    • 10.3.15.4. Strategic initiatives
  • 10.3.16. Curallux, LLC.
    • 10.3.16.1. Company overview
    • 10.3.16.2. Financial performance
    • 10.3.16.3. Product benchmarking
    • 10.3.16.4. Strategic initiatives
  • 10.3.17. Apira Science Inc. (iGROW Laser)
    • 10.3.17.1. Company overview
    • 10.3.17.2. Financial performance
    • 10.3.17.3. Product benchmarking
    • 10.3.17.4. Strategic initiatives
  • 10.3.18. Revian Inc.
    • 10.3.18.1. Company overview
    • 10.3.18.2. Financial performance
    • 10.3.18.3. Product benchmarking
    • 10.3.18.4. Strategic initiatives
  • 10.3.19. Theradome
    • 10.3.19.1. Company overview
    • 10.3.19.2. Financial performance
    • 10.3.19.3. Product benchmarking
    • 10.3.19.4. Strategic initiatives
  • 10.3.20. Lutronic
    • 10.3.20.1. Company overview
    • 10.3.20.2. Financial performance
    • 10.3.20.3. Product benchmarking
    • 10.3.20.4. Strategic initiatives